EdgarLookup

AYTU BIOPHARMA, INC — All Filings

890 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 10KSB 10QSB 10QSB/A 3 3/A 4 4/A 424B2 424B3 424B4 424B5 425 5 8-A12B 8-A12G 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEF 14C DEFA14A DEL AM DRS EFFECT FWP NT 10-K NT 10-Q POS AM PRE 14A PRE 14C PRER14A REGDEX S-1 S-1/A S-1MEF S-3 S-3/A S-4 S-4/A S-8 SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SC TO-I SC TO-I/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 0000919574-19-006686 Nov 1, 2019 Oct 30, 2019
D 0001654954-19-012195 Oct 31, 2019
SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-19-007779 Oct 21, 2019
SC 13D/A 0000919574-19-006449 Oct 16, 2019
4 0000919574-19-006450 Oct 16, 2019 Oct 11, 2019
8-K CURRENT REPORT 0001654954-19-011717 Oct 15, 2019 Oct 10, 2019
425 425 0001654954-19-011709 Oct 15, 2019
425 0001654954-19-011713 Oct 15, 2019
8-K CURRENT REPORT 0001654954-19-011716 Oct 15, 2019 Oct 11, 2019
425 425 0001654954-19-011428 Oct 3, 2019
8-K CURRENT REPORT 0001654954-19-011132 Sep 26, 2019
425 425 0001654954-19-011153 Sep 26, 2019
10-K ANNUAL REPORT 0001654954-19-011147 Sep 26, 2019 Jun 30, 2019
425 425 0001654954-19-010996 Sep 23, 2019
8-K FORM 8-K 0001654954-19-010889 Sep 18, 2019 Sep 12, 2019
SC 13D/A 0000919574-19-005928 Sep 18, 2019
425 425 0001654954-19-010664 Sep 12, 2019
425 425 0001654954-19-010608 Sep 12, 2019
SC 13G/A SC 13G/A 0001193125-19-241442 Sep 10, 2019
8-K FORM 8-K 0001654954-19-008769 Aug 2, 2019 Jul 29, 2019
10-Q/A AMENDMENT NO. 1 0001654954-19-005834 May 14, 2019 Dec 31, 2018
8-K CURRENT REPORT 0001654954-19-005838 May 14, 2019
10-Q QUARTERLY REPORT 0001654954-19-005839 May 14, 2019 Mar 31, 2019
8-K CURRENT REPORT 0001654954-19-005160 May 2, 2019 May 1, 2019
8-K CURRENT REPORT 0001654954-19-004897 Apr 26, 2019 Apr 24, 2019
SC 13D/A 0000919574-19-003012 Apr 23, 2019
4 0000919574-19-003010 Apr 22, 2019 Apr 18, 2019
8-K CURRENT REPORT 0001654954-19-004590 Apr 19, 2019 Apr 18, 2019
8-K CURRENT REPORT 0001654954-19-004575 Apr 18, 2019 Apr 15, 2019
8-K CURRENT REPORT 0001654954-19-004366 Apr 15, 2019 Apr 12, 2019
SC 13G/A SCHEDULE 13-G AMENDMENT 0001706226-19-000003 Mar 27, 2019
SC 13G/A SCHEDULE 13-G AMENDMENT 0001706226-19-000004 Mar 27, 2019
SC 13G SC 13G 0001193125-19-067843 Mar 8, 2019
DEF 14A PRIMARY DOCUMENT 0001654954-19-001949 Feb 25, 2019
DEFA14A DEFA14A 0001654954-19-001951 Feb 25, 2019
4 PRIMARY DOCUMENT 0001654954-19-001667 Feb 15, 2019 Feb 13, 2019
3 0000919574-19-001859 Feb 15, 2019 Feb 5, 2019
SC 13D 0000919574-19-001855 Feb 15, 2019
SC 13G/A 0000921895-19-000360 Feb 14, 2019
SC 13G/A SC 13G/A 0001104659-19-008590 Feb 14, 2019
SC 13G/A 0000919574-19-001586 Feb 14, 2019
SC 13G/A AYTU BIOSCIENCE, INC. 0000902664-19-001060 Feb 14, 2019
4 PRIMARY DOCUMENT 0001654954-19-001562 Feb 14, 2019 Feb 13, 2019
PRE 14A PRE 14A 0001654954-19-001580 Feb 14, 2019 Apr 12, 2019
8-K CURRENT REPORT 0001654954-19-001146 Feb 7, 2019
10-Q QUARTERLY REPORT 0001654954-19-001148 Feb 7, 2019 Dec 31, 2018
SC 13G AYTU 13G 0001393825-19-000045 Feb 1, 2019
SC 13G/A AYTU BIOSCIENCE, INC. 0000902664-19-000191 Jan 15, 2019
SC 13G/A 0000919574-19-000153 Jan 8, 2019
4 0001213900-18-017852 Dec 26, 2018 Dec 21, 2018